MoneyWorks4Me

A decent increase of about 27.27% in the sales to Rs. 2130.52 millions was observed for the quarter ended March 2026. The sales figure stood at Rs. 1674.08 millions during the year-ago period.Net profit for the quarter ended March 2026 increased significantly by 56.45% to Rs. 110.64 millions from Rs. 70.72 millions.OP of the company witnessed a marginal growth to 291.30 millions from 174.39 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 2130.52 1674.08 27.27 6391.21 4562.68 40.08 6391.21 4562.68 40.08
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 291.30 174.39 67.04 947.94 550.97 72.05 947.94 550.97 72.05
Interest 144.85 81.47 77.80 392.98 223.77 75.62 392.98 223.77 75.62
PBDT 146.45 92.92 57.61 554.96 327.20 69.61 554.96 327.20 69.61
Depreciation 31.13 12.50 149.04 79.14 44.49 77.88 79.14 44.49 77.88
PBT 115.32 80.42 43.40 475.82 282.71 68.31 475.82 282.71 68.31
TAX 4.68 9.70 -51.75 143.75 74.63 92.62 143.75 74.63 92.62
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 110.64 70.72 56.45 332.07 208.08 59.59 332.07 208.08 59.59
Equity 54.73 47.22 15.90 54.73 47.22 15.90 54.73 47.22 15.90
PBIDTM(%) 13.67 10.42 31.25 14.83 12.08 22.83 14.83 12.08 22.83
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..